日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study

TOPAZ-1 3期研究中晚期胆道癌患者总生存期的预测因素

He, Aiwu R; Bouattour, Mohamed; Gupta, Vineet G; Evesque, Ludovic; Zhen, David B; Park, Joon Oh; Sookprasert, Aumkhae; Salvatierra, Alejandro; Vaccaro, Gina; Oh, Sang Cheul; Ostoich, Sandra Anabel; Satoh, Taroh; Kuzko, Aleksandra; Żotkiewicz, Magdalena; Rokutanda, Nana; Oh, Do-Youn

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma.

循环肿瘤DNA能够很好地预测晚期胃食管腺癌患者接受化疗联合免疫检查点抑制剂治疗的疗效

Tougeron David, Louvet Christophe, Desramé Jérôme, Evesque Ludovic, Angelergues Antoine, Carnot Aurélien, Breysacher Gilles, Zaanan Aziz, Etchepare Nicolas, Mabro May, Kaluzinski Laure, Petorin Caroline, Chibaudel Benoist, Aparicio Thomas, Bodere Anaïs, Rinaldi Yves, Le Malicot Karine, Emile Jean-François, Lepage Côme, Baures Aurélia, Djamai Hanane, Taly Valérie, Laurent-Puig Pierre

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial

FOLFIRI联合度伐利尤单抗(加或不加曲美利木单抗)二线治疗晚期胃癌或胃食管交界处腺癌:PRODIGE 59-FFCD 1707-DURIGAST随机临床试验

Tougeron, David; Dahan, Laetitia; Evesque, Ludovic; Le Malicot, Karine; El Hajbi, Farid; Aparicio, Thomas; Bouché, Olivier; Bonichon Lamichhane, Nathalie; Chibaudel, Benoist; Angelergues, Antoine; Bodere, Anaïs; Phelip, Jean-Marc; Mabro, May; Kaluzinski, Laure; Petorin, Caroline; Breysacher, Gilles; Rinaldi, Yves; Zaanan, Aziz; Smith, Denis; Gouttebel, Marie-Claude; Perret, Clément; Etchepare, Nicolas; Emile, Jean-François; Sanfourche, Ivan; Di Fiore, Frédéric; Lepage, Côme; Artru, Pascal; Louvet, Christophe

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial

利沃塞尼(一种 VEGFR-2 抑制剂)单药治疗既往接受过治疗的晚期或转移性胃癌或胃食管交界处癌患者(ANGEL 研究):一项国际性、随机、安慰剂对照的 3 期试验

Kang, Yoon-Koo; Ryu, Min-Hee; Di Bartolomeo, Maria; Chau, Ian; Yoon, Harry; Kim, Jong Gwang; Lee, Keun-Wook; Oh, Sang Chul; Takashima, Atsuo; Kryzhanivska, Anna; Chao, Yee; Evesque, Ludovic; Schenker, Michael; McGinn, Arlo; Zhao, Yufan; Lee, Jennifer; Wyrwicz, Lucjan; Boku, Narikazu

Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study

瑞戈非尼联合FOLFIRINOX方案作为RAS突变转移性结直肠癌患者的一线治疗(FOLFIRINOX-R试验):一项剂量递增研究

Adenis, Antoine; Ghiringhelli, François; Gauthier, Ludovic; Mazard, Thibault; Evesque, Ludovic; Evrard, Alexandre; Chalbos, Patrick; Moussion, Aurore; Gourgou, Sophie; Ychou, Marc

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial

阿维鲁单抗对比标准二线化疗治疗伴有微卫星不稳定性转移性结直肠癌患者:一项随机临床试验

Taïeb, Julien; Bouche, Olivier; André, Thierry; Le Malicot, Karine; Laurent-Puig, Pierre; Bez, Jérémie; Toullec, Clémence; Borg, Christophe; Randrian, Violaine; Evesque, Ludovic; Corbinais, Stéphane; Perrier, Hervé; Buecher, Bruno; Di Fiore, Frederic; Gallois, Claire; Emile, Jean Francois; Lepage, Côme; Elhajbi, Farid; Tougeron, David

Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma

基于血液的RNA特征在转移性胰腺腺癌吉西他滨治疗中的应用性能

Piquemal, David; Bruno, Roman; Bournet, Barbara; Ghiringhelli, Francois; Noguier, Florian; Canivet, Cindy; Bertaut, Aurélie; Pierrat, Fabien; Evesque, Ludovic; Gamez, Amelia; Cros, Jerome; Rederstorff, Emilie; Petit, Erwan; Adnet, Johan; Saint, Angélique; Drouillard, Antoine; Kempf, Emmanuelle; Soularue, Emilie; Vincent, Julie; Baumgaertner, Isabelle; Hennequin, Audrey; Tournigand, Christophe; Lopez Trabada Ataz, Daniel; Bengrine, Leila; Lepage, Come; Manfredi, Sylvain; Afchain, Pauline; Trouilloud, Isabelle; Gagnaire, Alice; LoConte, Noelle K; Bachet, Jean-Baptiste

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial

FOLFIRINOX方案与吉西他滨方案作为胰腺癌辅助治疗的五年疗效:一项随机临床试验

Conroy, Thierry; Castan, Florence; Lopez, Anthony; Turpin, Anthony; Ben Abdelghani, Meher; Wei, Alice C; Mitry, Emmanuel; Biagi, James J; Evesque, Ludovic; Artru, Pascal; Lecomte, Thierry; Assenat, Eric; Bauguion, Lucile; Ychou, Marc; Bouché, Olivier; Monard, Laure; Lambert, Aurélien; Hammel, Pascal

Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma

II期INTERACT-ION研究:伊扎贝利单抗(BI 754091)联合mDCF(多西他赛、顺铂和5-氟尿嘧啶)化疗后序贯放化疗治疗III期肛门鳞状细胞癌患者

Kim, Stefano; Boustani, Jihane; Vernerey, Dewi; Vendrely, Véronique; Evesque, Ludovic; Francois, Eric; Quero, Laurent; Ghiringhelli, Francois; de la Fouchardière, Christelle; Dahan, Laëtitia; Bouché, Oliver; Chibaudel, Benoist; Hajbi, Farid El; Vernet, Chloé; Rebucci-Peixoto, Magali; Feuersinger, Alexandra; Maritaz, Christophe; Borg, Christophe

FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer

FOLFIRINOX-R 研究设计:一项 I/II 期临床试验,评估 FOLFIRINOX 联合瑞戈非尼作为一线疗法治疗 RAS 突变型不可切除转移性结直肠癌患者的疗效。

Adenis, Antoine; Mazard, Thibault; Fraisse, Julien; Chalbos, Patrick; Pastor, Brice; Evesque, Ludovic; Ghiringhelli, Francois; Mollevi, Caroline; Delaine, Stéphanie; Ychou, Marc